Call Options Transactions Made in Q3 2022 in Adaptimmune Therapeutics PLC (ADAP)
This table provides information about the institutional ownership of Adaptimmune Therapeutics PLC (ADAP) during Q3 2022. The information is specifically focused on institutions that hold call options of Adaptimmune Therapeutics PLC.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 14, 2022
Q3 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
CALL |
-36.5K- 62.29% |
$38.7K - $88K
|
22.1K
$14.6K
|